{"id":"NCT00224484","sponsor":"GlaxoSmithKline","briefTitle":"Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old","officialTitle":"A Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline Biologicals' Herpes Simplex Candidate Vaccine (gD2-AS04) in Healthy HSV Seronegative and Seropositive Female Subjects Aged 10-17 Years.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-04-07","primaryCompletion":"2007-07-24","completion":"2007-07-24","firstPosted":"2005-09-23","resultsPosted":"2017-04-10","lastUpdate":"2019-01-07"},"enrollment":5960,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Herpes Simplex"],"interventions":[{"type":"BIOLOGICAL","name":"GSK208141","otherNames":["Herpes simplex vaccine","gD2-AS04 vaccine"]},{"type":"BIOLOGICAL","name":"Havrix (investigational formulation)","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"GD2-AS04 GROUP","type":"EXPERIMENTAL"},{"label":"HAVRIX GROUP","type":"ACTIVE_COMPARATOR"},{"label":"SALINE GROUP","type":"PLACEBO_COMPARATOR"}],"summary":"Main goal of this study is to compare the occurrence of serious adverse events (SAEs) between the herpes simplex (gD2-AS04) vaccine group and the Saline control group throughout the study period (up to month 12).\n\nThe Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.","primaryOutcome":{"measure":"Number of Subjects With Serious Adverse Events (SAEs)","timeFrame":"From Month 0 to Month 12","effectByArm":[{"arm":"gD2-AS04 Group","deltaMin":71,"sd":null},{"arm":"Havrix Group","deltaMin":42,"sd":null},{"arm":"Saline Group","deltaMin":37,"sd":null}],"pValues":[]},"eligibility":{"minAge":"10 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":18},"locations":{"siteCount":151,"countries":["United States","Australia","Belgium","Canada","Denmark","Estonia","France","Greece","Hungary","Iceland","Lithuania","Netherlands","New Zealand","Norway","Romania","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["23313657","23850416","18845199"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":71,"n":2977},"commonTop":["Pain","Headache","Fatigue","Malaise","Redness"]}}